Marco Alicia, Gargallo Marta, Ciriza Jesús, Royo-Cañas María, Ibáñez-Deler Alejandro, Remacha Ana Rosa, Fons-Contreras María, Malo Clara
Faculty of Medicine, University of Zaragoza, Saragossa, 50018, Spain.
Institute for Health Research Aragón (IIS Aragón), Saragossa, 50009, Spain.
J Ovarian Res. 2025 May 3;18(1):94. doi: 10.1186/s13048-025-01593-7.
To study innovative approaches to ovarian tissue cryopreservation, a critical issue for fertility preservation in pediatric cancer patients. Despite historical attempts, recent advances in cancer treatment have underscored the urgent need for more effective and reliable ovarian tissue cryopreservation methods. Our research aims to evaluate if decreasing the rigidity of stroma before cryopreservation by investigating pre-treatments with enzymes can enhance the quality of ovarian tissue post-thawing.
Our research evaluated the use of five commonly used enzymes to disaggregate tissue (trypLE, collagenase, dispase, accutase and hyaluronidase) before freezing ovarian tissue to decrease rigidity and facilitate cryopreservation. Sheep ovaries, with high similarity to human ovaries, were used as an animal model. Tissue structure, cell proliferation, apoptosis and viability were assessed before and after thawing.
Our findings showed that enzymatic treatment with trypLE before freezing offered immediate benefits post-thawing with the highest viability values and percentage of intact follicles. A decrease in viability was observed after thawing and culturing the samples. The pretreatment with accutase damaged the tissue severely with also the lowest viability values. Ki67-positive follicles and stromal cells were observed in fresh samples, but only trypLE and hyaluronidase maintained Ki67-positive antral follicles after 2 days culture. Besides, only trypLE maintained all follicles negative to caspase-3 after thawing, and 7 days after culture primordial follicles were apoptotic in all treatments apart from trypLE.
our findings suggest that trypLE pretreatment could provide a beneficial approach for maintaining the functions and viability of cryopreserved ovaries after thawing. Further research is needed to fully understand their impact and optimize cryopreservation protocols in this important clinical context.
研究卵巢组织冷冻保存的创新方法,这是儿科癌症患者生育力保存的关键问题。尽管过去曾有过尝试,但癌症治疗的最新进展凸显了对更有效、更可靠的卵巢组织冷冻保存方法的迫切需求。我们的研究旨在通过研究酶预处理来评估在冷冻保存前降低基质硬度是否能提高解冻后卵巢组织的质量。
我们的研究评估了在冷冻卵巢组织以降低硬度并促进冷冻保存之前,使用五种常用酶(TrypLE、胶原酶、分散酶、Accutase和透明质酸酶)来分解组织。与人卵巢高度相似的绵羊卵巢被用作动物模型。在解冻前后评估组织结构、细胞增殖、凋亡和活力。
我们的研究结果表明,冷冻前用TrypLE进行酶处理在解冻后具有直接益处,具有最高的活力值和完整卵泡百分比。解冻并培养样品后观察到活力下降。用Accutase预处理严重损害了组织,活力值也最低。在新鲜样品中观察到Ki67阳性卵泡和基质细胞,但在培养2天后,只有TrypLE和透明质酸酶维持了Ki67阳性窦卵泡。此外,只有TrypLE在解冻后使所有卵泡对caspase-3呈阴性,除TrypLE外,所有处理在培养7天后原始卵泡均发生凋亡。
我们的研究结果表明,TrypLE预处理可为维持解冻后冷冻卵巢的功能和活力提供一种有益的方法。需要进一步研究以充分了解它们的影响,并在这一重要临床背景下优化冷冻保存方案。